Amerise Biosciences Ltd.
AMERISE.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$52.86M
Close$
$0.09
89.4% downside
Current Fair Value
89.4% downsideOvervalued by 89.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $52.86 Million |
|---|---|
| Enterprise Value | $46.94 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.22 |
| Outstanding Shares | 66,069,000 |
Return
| Return on Equity | -0.98% |
|---|---|
| Return on Assets | -0.71% |
| Return on Invested Capital | -1.81% |
Valuation & Multiples
| P/E Ratio | -111.11 |
|---|---|
| PEG | -12.28 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 59.26 |
| Enterprise Value to EBIT | -48.04 |
| Enterprise Value to Net Income | -90 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Amerise Biosciences Ltd.
0
CEO: Albert Hines Founded on August 27, 1984, and headquartered in Ahmedabad, India, Amerise Biosciences Ltd. previously manufactured plastic items. The company is currently not engaged in any business operations.